Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review

SKU ID :GD-12879845 | Published Date: 20-Dec-2018 | No. of pages: 46
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Section 1 - About the Company 5 Puma Biotechnology Inc - Key Facts 5 Puma Biotechnology Inc - Key Employees 6 Puma Biotechnology Inc - Key Employee Biographies 7 Puma Biotechnology Inc - Major Products and Services 8 Puma Biotechnology Inc - History 9 Puma Biotechnology Inc - Company Statement 10 Puma Biotechnology Inc - Locations And Subsidiaries 11 Head Office 11 Other Locations & Subsidiaries 11 Section 2 – Company Analysis 12 Company Overview 12 Puma Biotechnology Inc - Business Description 13 Puma Biotechnology Inc - Corporate Strategy 14 Puma Biotechnology Inc - SWOT Analysis 15 SWOT Analysis - Overview 15 Puma Biotechnology Inc - Strengths 15 Puma Biotechnology Inc - Weaknesses 16 Puma Biotechnology Inc - Opportunities 17 Puma Biotechnology Inc - Threats 18 Puma Biotechnology Inc - Key Competitors 19 Section 3 – Company Financial Ratios 20 Financial Ratios - Capital Market Ratios 20 Financial Ratios - Annual Ratios 21 Performance Chart 23 Financial Performance 23 Financial Ratios - Interim Ratios 24 Financial Ratios - Ratio Charts 25 Section 4 – Company’s Lifesciences Financial Deals and Alliances 26 Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26 Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27 Puma Biotechnology Inc, Recent Deals Summary 28 Section 5 – Company’s Recent Developments 29 Aug 09, 2018: Puma Biotechnology reports second quarter 2018 financial results 29 May 09, 2018: Puma Biotechnology Reports First Quarter 2018 Financial Results 31 Dec 14, 2017: Puma Biotechnology Added to NASDAQ Biotechnology Index 33 Nov 09, 2017: Puma Biotechnology Reports Third Quarter 2017 Financial Results 34 Nov 02, 2017: Puma Biotechnology Secures $100 Million Term Loan from Oxford Finance and Silicon Valley Bank 35 Aug 09, 2017: Puma Biotechnology Reports Second Quarter 2017 Financial Results 36 May 10, 2017: Puma Biotechnology Reports First Quarter 2017 Financial Results 38 Mar 01, 2017: Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results 40 Section 6 – Appendix 42 Methodology 42 Ratio Definitions 42 About GlobalData 46 Contact Us 46 Disclaimer 46
List of Tables Puma Biotechnology Inc, Key Facts 5 Puma Biotechnology Inc, Key Employees 6 Puma Biotechnology Inc, Key Employee Biographies 7 Puma Biotechnology Inc, Major Products and Services 8 Puma Biotechnology Inc, History 9 Puma Biotechnology Inc, Subsidiaries 11 Puma Biotechnology Inc, Key Competitors 19 Puma Biotechnology Inc, Ratios based on current share price 20 Puma Biotechnology Inc, Annual Ratios 21 Puma Biotechnology Inc, Annual Ratios (Cont...1) 22 Puma Biotechnology Inc, Interim Ratios 24 Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26 Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27 Puma Biotechnology Inc, Recent Deals Summary 28 Currency Codes 42 Capital Market Ratios 42 Equity Ratios 43 Profitability Ratios 43 Cost Ratios 44 Liquidity Ratios 44 Leverage Ratios 45 Efficiency Ratios 45List of Figures Puma Biotechnology Inc, Performance Chart (2013 - 2017) 23 Puma Biotechnology Inc, Ratio Charts 25 Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26 Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27
Five Prime Therapeutics Inc Fate Therapeutics Inc Corcept Therapeutics Inc Cascadian Therapeutics Inc Ayala Pharmaceuticals Inc
  • PRICE
  • $125
    $375

Our Clients